Navigation Links
Tiens Biotech Group (USA) Reports Record Twelve-Month Results
Date:3/31/2009

products; (v) whether Tianshi Engineering, the Company's affiliate which sells its products in China, obtains a direct selling license in China; and (vi) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission which are available for review at http://www.sec.gov under "Search for Company Filings."

                                -Tables Follow-



                TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES

        CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME
                 FOR THE YEARS ENDED DECEMBER 31, 2008 AND 2007
                                                                   2007
                                                                As Adjusted
                                                    2008          (Note 1)
    REVENUE - RELATED PARTIES                   $77,247,898     $54,900,060

    COST OF SALES - RELATED PARTIES              24,870,178      16,526,695

    GROSS PROFIT                                 52,377,720      38,373,365

    SELLING, GENERAL AND ADMINISTRATIVE
     EXPENSES                                    18,574,719      14,921,414

    INCOME FROM OPERATIONS                       33,803,001      23,451,951

      (Interest expense)                           (266,273)       (399,773)
      Interest income                               881,070       3,038,755
      Other (expense) income, net                (2,099,913)     (1,161,071)

    OTHER (EXPENSE) INCOME, NET                  (1,485,116)      1,477,911

    INCOME BEFORE PROVISION FOR INCOME TAXES
     AND MINORITY INTEREST                       32,317,885      24,929,862

    PROVISION FOR INCOME TAXES                    2,345,474       2,026,875

    INCOME BEFORE MINORITY INTEREST              29,972,411      22,902,987

    MINORITY INTEREST                             2,315,215    
'/>"/>
SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Tiens Biotech Group (USA) Reports First Quarter Results
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Biotech Finishes on a High in August, Burrill Report Says
4. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
5. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
6. Biotech delists shares from TSXV, continues OTCBB trading
7. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
8. MichBio Announces Formation of Biotechnology Legislative Caucus
9. Oncolytics Biotech Inc. announces approval for UK clinical trial
10. Not just humans benefit from animal biotechnology
11. Biotech adds Central American markets to Sucanon distribution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MA (PRWEB) May 28, 2015 Workers’ compensation ... the typical state, a recent study by the Workers ... falling over a three-year period. , The WCRI study, ... in which workers missed seven days or more of work ... months, the average 2011 Michigan claim was 4 percent lower ...
(Date:5/28/2015)... Ticket Down is a reputable source of presale tickets ... Argentina in early September. , Two of the best ... pitch at AT&T Stadium in Arlington/Dallas, TX. Mexico and Argentina ... Tuesday, September 8th at 9 p.m. The match will feature ... some of the most loved players in the entire sport. ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 According ... ( http://www.idataresearch.com ), the shoulder reconstruction device market, ... small bone & joint market in 2014. This ... arthroplasty procedures in the U.S. due to increased ... device technology resulting in greater patient outcomes. Therefore, ...
(Date:5/28/2015)... The connected car is gaining more traction with ... have some iteration of a connected offering in the ... companies as the data collected can be used to ... (UBI). This is the primary reason that 800+ senior ... Conference & Exhibition. , Andrew Pym, TU Automotive’s ...
(Date:5/28/2015)... lifeIMAGE announced today that it ... by Cambia Health Solutions (Portland, Ore.), a ... care by creating a person-focused and economically sustainable system. ... exchanging medical imaging, will use this financing to expand ... of its network capabilities and implement the next phases ...
Breaking Medicine News(10 mins):Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 2Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 3Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4
... million in the latest round of National Health and ... ever NHMRC funding amount for the greatest number of ... health and medical research grants today. , Monash University ... 62 individual projects, including: , $1.8 million ...
... Satyam Computer,Services Ltd. (NYSE: SAY ), a ... reported US GAAP results for its second,quarter, which ... Despite a challenging market that impacted several key ... exceeded its guidance in,the second quarter. Revenue was ...
... Health Message to Austin,s American,Heart Association Heart Walk, ... was the leading,cause of death among Texans in ... People with heart disease are at an increased ... flu. Therefore, the,U.S. Centers for Disease Control and ...
... Kicks Off Regional Expansion With Mobile Healthy,Living Experience ... World of Grains brand announced today,their expansion ... brand,will host a Mobile Healthy Living Experience at ... of making simple, better decisions,to improve their lifestyle ...
... Services; Kathleen A. Walsh named VP, Product Management; Gilbert ... for team to commercialize and support initial ... of NewCardio,s platform technology, SANTA CLARA, Calif., Oct. 17 ... services company, today,announced the hiring of three key executives to ...
... Cohera Medical Inc. today announced,it has secured $16.1 ... ongoing,development of TissuGlu(R), a novel surgical adhesive for ... led by Bradford Capital Partners, included,participation from existing ... financing provides the company with sufficient capital to ...
Cached Medicine News:Health News:Monash wins $32m for health and medical research 2Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 2Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 3Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 4Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 5Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 6Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 7Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 8Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 9Health News:Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets 10Health News:Huston Street Joins Mended Hearts with an Important Heart Health Message: Get Your Flu Shot! 2Health News:Huston Street Joins Mended Hearts with an Important Heart Health Message: Get Your Flu Shot! 3Health News:World of Grains(TM) - The Cookie That's One Bite Better Comes to a Store Near You 2Health News:World of Grains(TM) - The Cookie That's One Bite Better Comes to a Store Near You 3Health News:NewCardio Announces New Client Services Team 2Health News:NewCardio Announces New Client Services Team 3Health News:NewCardio Announces New Client Services Team 4Health News:Cohera Medical Secures $16.1 Million in Series B Financing 2
(Date:5/28/2015)... , May 28, 2015 ... of cartilage, cellular, bone, skin and soft-tissue allografts ... to advance patient healing, today announced that AlloWrap® ... been moved to the high-cost reimbursement category. ... reach doctors and their patients," said Kimberly ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of the "United States ... report to their offering.      (Logo: ... adhesives in the United States ... 2020 Medical device manufacturers across ...
(Date:5/28/2015)... 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO ... Martell , to the position of Executive Chairman. Mr. ... Board of Directors. In this new role, he will ... refine and execute on the strategic plan to transition ... for orphan oncology indications with high unmet medical need. ...
Breaking Medicine Technology:AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5
... From today, an innovative non-drug, non-invasive treatment ... all hypertensive patients on NHS prescription. RESPeRATE is an ... When used for just 15 minutes a day, at ... significant, all-day blood pressure reduction beyond that seen with ...
... Therapeutics, Inc. (NASDAQ: HALO ) today presented ... tolerability study of HTI-501 (an investigational, conditionally active recombinant ... International Academy of Cosmetic Dermatology in Cancun, Mexico. Data ... portion of the clinical trial. The Phase 1/2 trial ...
Cached Medicine Technology:NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 2NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 3NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription 4HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 2HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 3
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
Medicine Products: